GlassScriptPhysician profile
Steven R Zhao
NPI 1457779068
$4,234.30
in general payments reported to CMS, 2019-2025
24 companies · $763 in 2025
The $763 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2021: $94.59 · 2022: $586 · 2023: $1,465 · 2024: $1,086 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,897 · Consulting Fee: $400 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,896.84 |
| Consulting Fee | $400.00 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,056.52 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $914.77 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $400.00 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $336.73 | 2021-2024 | Tezspire, Breztri |
| Genzyme Corporation | $194.76 | 2023-2025 | |
| Edwards Lifesciences Corporation | $171.95 | 2024 | Sapien 3 Ultra Resilia |
| United Therapeutics Corporation | $139.89 | 2023 | Tyvaso |
| Grifols USA, LLC | $139.73 | 2022-2025 | Prolastin-C Liquid |
| Inspire Medical Systems, INC. | $128.13 | 2023 | Inspire |
| Regeneron Healthcare Solutions, INC. | $122.18 | 2023-2024 | Dupixent |
| Insmed, INC. | $116.79 | 2025 | Arikayce, Brinsupri |
| Vapotherm INC | $114.48 | 2019 | |
| Electromed, INC. | $72.34 | 2022-2023 | Smartvest |
| Mylan Specialty L.P. | $63.63 | 2022-2024 | Yupelri |
| Baxter Healthcare | $51.33 | 2024-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $34.65 | 2025 | Yupelri |
| Philips North America LLC | $34.24 | 2023 | |
| Pfizer INC. | $26.79 | 2023 | |
| Fisher & Paykel Healthcare INC | $23.18 | 2025 | Fisher & Paykel Healthcare |
| Avadel Cns Pharmaceuticals, LLC | $22.02 | 2025 | Lumryz |
| Actelion Pharmaceuticals US, INC. | $21.30 | 2024 | Uptravi, Opsumit |
| Phadia US INC. | $18.47 | 2023 | Immunocap |
| Azurity Pharmaceuticals, INC. | $15.45 | 2024 | Horizant |
| E.R. Squibb & Sons, L.L.C. | $14.97 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Zhao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.